お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は肺がんの液体検査市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは肺がんの液体検査の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の肺がんの液体検査市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは肺がんの液体検査のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に肺がんの液体検査市場を分類しています。本研究に含まれる主な企業は：Biocept、Exosome Diagnostics、F. Hoffmann-La Roche、Qiagen、Accuragen、Agena Bioscience、Bard1、Bgi

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    CTCs
    CtDNA
    Exosomes And RNA
    Others

用途別の市場セグメント：
    Clinics
    Hospitals
    Physicians' Office Laboratories

本レポートの詳細内容
世界の肺がんの液体検査市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、肺がんの液体検査タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の肺がんの液体検査収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の肺がんの液体検査市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、肺がんの液体検査市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

肺がんの液体検査のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：肺がんの液体検査のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：肺がんの液体検査の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章肺がんの液体検査企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：肺がんの液体検査の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：肺がんの液体検査の主要企業の概要を提供し、製品の説明と仕様、肺がんの液体検査の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.

Market Analysis and Insights: Global Lung Cancer Liquid Biopsy Market
The global Lung Cancer Liquid Biopsy market is projected to grow from US$ 492.9 million in 2024 to US$ 1082 million by 2030, at a Compound Annual Growth Rate (CAGR) of 14.0% during the forecast period.
CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.

Report Covers:
This report presents an overview of global market for Lung Cancer Liquid Biopsy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Lung Cancer Liquid Biopsy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Lung Cancer Liquid Biopsy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lung Cancer Liquid Biopsy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Lung Cancer Liquid Biopsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Lung Cancer Liquid Biopsy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Biocept, Exosome Diagnostics, F. Hoffmann-La Roche, Qiagen, Accuragen, Agena Bioscience, Bard1 and Bgi, etc.
Market Segmentation
By Company
    Biocept
    Exosome Diagnostics
    F. Hoffmann-La Roche
    Qiagen
    Accuragen
    Agena Bioscience
    Bard1
    Bgi

Segment by Type
    CTCs
    CtDNA
    Exosomes And RNA
    Others

Segment by Application
    Clinics
    Hospitals
    Physicians' Office Laboratories

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Lung Cancer Liquid Biopsy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Liquid Biopsy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Cancer Liquid Biopsy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of CTCs
    Table 3. Key Players of CtDNA
    Table 4. Key Players of Exosomes And RNA
    Table 5. Key Players of Others
    Table 6. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Lung Cancer Liquid Biopsy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Lung Cancer Liquid Biopsy Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Lung Cancer Liquid Biopsy Market Share by Region (2019-2024)
    Table 10. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Lung Cancer Liquid Biopsy Market Share by Region (2025-2030)
    Table 12. Lung Cancer Liquid Biopsy Market Trends
    Table 13. Lung Cancer Liquid Biopsy Market Drivers
    Table 14. Lung Cancer Liquid Biopsy Market Challenges
    Table 15. Lung Cancer Liquid Biopsy Market Restraints
    Table 16. Global Lung Cancer Liquid Biopsy Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Lung Cancer Liquid Biopsy Revenue Share by Players (2019-2024)
    Table 18. Global Top Lung Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2023)
    Table 19. Global Lung Cancer Liquid Biopsy Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Lung Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Lung Cancer Liquid Biopsy, Headquarters and Area Served
    Table 22. Global Key Players of Lung Cancer Liquid Biopsy, Product and Application
    Table 23. Global Key Players of Lung Cancer Liquid Biopsy, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Lung Cancer Liquid Biopsy Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2019-2024)
    Table 27. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2025-2030)
    Table 29. Global Lung Cancer Liquid Biopsy Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Lung Cancer Liquid Biopsy Revenue Share by Application (2019-2024)
    Table 31. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Lung Cancer Liquid Biopsy Revenue Share by Application (2025-2030)
    Table 33. North America Lung Cancer Liquid Biopsy Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Lung Cancer Liquid Biopsy Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Lung Cancer Liquid Biopsy Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Lung Cancer Liquid Biopsy Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Lung Cancer Liquid Biopsy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Lung Cancer Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Lung Cancer Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Lung Cancer Liquid Biopsy Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Lung Cancer Liquid Biopsy Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Lung Cancer Liquid Biopsy Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Lung Cancer Liquid Biopsy Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Lung Cancer Liquid Biopsy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Lung Cancer Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Lung Cancer Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Lung Cancer Liquid Biopsy Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Lung Cancer Liquid Biopsy Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Lung Cancer Liquid Biopsy Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Lung Cancer Liquid Biopsy Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Lung Cancer Liquid Biopsy Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Lung Cancer Liquid Biopsy Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Lung Cancer Liquid Biopsy Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Lung Cancer Liquid Biopsy Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Lung Cancer Liquid Biopsy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Lung Cancer Liquid Biopsy Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Lung Cancer Liquid Biopsy Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Biocept Company Details
    Table 66. Biocept Business Overview
    Table 67. Biocept Lung Cancer Liquid Biopsy Product
    Table 68. Biocept Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)
    Table 69. Biocept Recent Developments
    Table 70. Exosome Diagnostics Company Details
    Table 71. Exosome Diagnostics Business Overview
    Table 72. Exosome Diagnostics Lung Cancer Liquid Biopsy Product
    Table 73. Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)
    Table 74. Exosome Diagnostics Recent Developments
    Table 75. F. Hoffmann-La Roche Company Details
    Table 76. F. Hoffmann-La Roche Business Overview
    Table 77. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product
    Table 78. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)
    Table 79. F. Hoffmann-La Roche Recent Developments
    Table 80. Qiagen Company Details
    Table 81. Qiagen Business Overview
    Table 82. Qiagen Lung Cancer Liquid Biopsy Product
    Table 83. Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)
    Table 84. Qiagen Recent Developments
    Table 85. Accuragen Company Details
    Table 86. Accuragen Business Overview
    Table 87. Accuragen Lung Cancer Liquid Biopsy Product
    Table 88. Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)
    Table 89. Accuragen Recent Developments
    Table 90. Agena Bioscience Company Details
    Table 91. Agena Bioscience Business Overview
    Table 92. Agena Bioscience Lung Cancer Liquid Biopsy Product
    Table 93. Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)
    Table 94. Agena Bioscience Recent Developments
    Table 95. Bard1 Company Details
    Table 96. Bard1 Business Overview
    Table 97. Bard1 Lung Cancer Liquid Biopsy Product
    Table 98. Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)
    Table 99. Bard1 Recent Developments
    Table 100. Bgi Company Details
    Table 101. Bgi Business Overview
    Table 102. Bgi Lung Cancer Liquid Biopsy Product
    Table 103. Bgi Revenue in Lung Cancer Liquid Biopsy Business (2019-2024) & (US$ Million)
    Table 104. Bgi Recent Developments
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Lung Cancer Liquid Biopsy Market Share by Type: 2023 VS 2030
    Figure 3. CTCs Features
    Figure 4. CtDNA Features
    Figure 5. Exosomes And RNA Features
    Figure 6. Others Features
    Figure 7. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Lung Cancer Liquid Biopsy Market Share by Application: 2023 VS 2030
    Figure 9. Clinics Case Studies
    Figure 10. Hospitals Case Studies
    Figure 11. Physicians' Office Laboratories Case Studies
    Figure 12. Lung Cancer Liquid Biopsy Report Years Considered
    Figure 13. Global Lung Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Lung Cancer Liquid Biopsy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Lung Cancer Liquid Biopsy Market Share by Region: 2023 VS 2030
    Figure 16. Global Lung Cancer Liquid Biopsy Market Share by Players in 2023
    Figure 17. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2023
    Figure 19. North America Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Lung Cancer Liquid Biopsy Market Share by Type (2019-2030)
    Figure 21. North America Lung Cancer Liquid Biopsy Market Share by Application (2019-2030)
    Figure 22. North America Lung Cancer Liquid Biopsy Market Share by Country (2019-2030)
    Figure 23. United States Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Lung Cancer Liquid Biopsy Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Lung Cancer Liquid Biopsy Market Share by Type (2019-2030)
    Figure 27. Europe Lung Cancer Liquid Biopsy Market Share by Application (2019-2030)
    Figure 28. Europe Lung Cancer Liquid Biopsy Market Share by Country (2019-2030)
    Figure 29. Germany Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Lung Cancer Liquid Biopsy Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Lung Cancer Liquid Biopsy Market Share by Type (2019-2030)
    Figure 37. China Lung Cancer Liquid Biopsy Market Share by Application (2019-2030)
    Figure 38. Asia Lung Cancer Liquid Biopsy Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Lung Cancer Liquid Biopsy Market Share by Type (2019-2030)
    Figure 40. Asia Lung Cancer Liquid Biopsy Market Share by Application (2019-2030)
    Figure 41. Asia Lung Cancer Liquid Biopsy Market Share by Region (2019-2030)
    Figure 42. Japan Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Lung Cancer Liquid Biopsy Market Share by Country (2019-2030)
    Figure 52. Brazil Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Lung Cancer Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Biocept Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)
    Figure 59. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)
    Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)
    Figure 61. Qiagen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)
    Figure 62. Accuragen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)
    Figure 63. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)
    Figure 64. Bard1 Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)
    Figure 65. Bgi Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed